6 participants
Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-05-13
- Start Date:
- 2013-10-31
- Completion:
- 2014-08-31
Conditions
- Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
Interventions
- DRUG